Myriad Genetics and SOPHiA GENETICS Announce New Collaboration to Advance Prostate Genomic Instability Score Technology
Go back to Myriad Genetics and SOPHiA GENETICS Announce New Collaboration to Advance Prostate Genomic Instability Score Technology| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 1,853,952 | |||||
| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 5.57 +0.03 (0.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.54 | 52 Week High | $45.34 | |||
| Open | $5.60 | 52 Week Low | $15.92 | |||
| Day High | $5.74 | P/E | 2.39 | |||
| Day Low | $5.45 | EPS | $2.33 | |||
| Volume | 4,894,457 | |||||
| (NASDAQ: SOPH) | Delayed: 7.35 +0.42 (6.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.93 | 52 Week High | $ | |||
| Open | $6.99 | 52 Week Low | $ | |||
| Day High | $7.43 | P/E | N/A | |||
| Day Low | $6.98 | EPS | $ | |||
| Volume | 591,854 | |||||



